Blauvelt, A., S. Kempers, S. Forman, E. Lain, and S. Bruce. “Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s63, doi:10.25251/skin.4.supp.62.